VTR Ventas Inc.

Ventas Chairman and CEO Debra A. Cafaro Honored by Modern Healthcare as One of Top 25 Women Leaders in Healthcare

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Chairman and Chief Executive Officer Debra A. Cafaro was honored by Modern Healthcare magazine as one of the “Top 25 Women in Healthcare.” This is the third time Ms. Cafaro has been recognized by Modern Healthcare for her thought leadership in the industry.

“This honor is a reaffirmation of Ventas’s commitment to providing innovative long term capital solutions to top tier healthcare, senior living and research organizations, enabling them to fulfill their core mission of serving patients, families and communities,” said Ms. Cafaro. “Our experienced and cohesive team at Ventas is dedicated to our customers, and this recognition reflects the success of our team and our partners. As healthcare evolves and grows, Ventas remains focused on allocating capital to further innovation, efficiency and quality outcomes.”

The Modern Healthcare list is a biennial award honoring female executives from all sectors of the healthcare system who are developing policy, leading change and guiding healthcare delivery improvement. Ms. Cafaro was also recently named to Modern Healthcare’s list of the Top 100 People in Healthcare.

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,300 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, skilled nursing facilities, specialty hospitals and general acute care hospitals. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

Click here to subscribe to Mobile Alerts for Ventas, Inc.

EN
06/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ventas Inc.

Ventas Inc: 1 director

A director at Ventas Inc sold 23,500 shares at 64.232USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch